📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Seqens

1.1 - Company Overview

Seqens Logo

Seqens

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of integrated pharmaceutical synthesis and specialty ingredients, delivering market responsiveness and tailor-made solutions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Seqens

Javara Logo

Javara

HQ: United States Website
  • Description: Provider of integrated clinical research services to healthcare organizations, delivering turnkey, practice-based clinical trial infrastructure to expand access to clinical trials and change the clinical research experience for providers and patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Javara company profile →
CU Chemie Uetikon Logo

CU Chemie Uetikon

HQ: Germany Website
  • Description: Provider of chemical and pharmaceutical production services via a state-of-the-art multi purpose plant in Europe, featuring a high standard cGMP API-production facility (MPA P3) on its manufacturing site in Lahr, Germany. Core competence includes the custom synthesis of Fine Chemical Intermediates.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CU Chemie Uetikon company profile →
Iuvo Bioscience Logo

Iuvo Bioscience

HQ: United States Website
  • Description: Provider of preclinical testing, clinical research, and consulting services to the healthcare sector as a contract research organization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iuvo Bioscience company profile →
Vial Logo

Vial

HQ: United States Website
  • Description: Provider of advanced programs for clinics to conduct lower-cost trials, specializing in computationally designed therapeutics and leveraging technology to automate clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vial company profile →
Nelson Labs Logo

Nelson Labs

HQ: United States Website
  • Description: Provider of microbiological testing and consulting services for MedTech companies, offering analytical lab testing, method development and validation, stability studies, extractables and leachables testing, and support for regulatory submissions, product development, and quality assurance to ensure product safety, efficacy, and compliance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nelson Labs company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Seqens

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Seqens

2.2 - Growth funds investing in similar companies to Seqens

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Seqens

4.2 - Public trading comparable groups for Seqens

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Seqens

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Seqens

What does Seqens do?

Seqens is a provider of integrated pharmaceutical synthesis and specialty ingredients, delivering market responsiveness and tailor-made solutions.

Who are Seqens's competitors?

Seqens's competitors and similar companies include Javara, CU Chemie Uetikon, Iuvo Bioscience, Vial, and Nelson Labs.

Where is Seqens headquartered?

Seqens is headquartered in France.

How many employees does Seqens have?

Seqens has 1,000 employees 🔒.

When was Seqens founded?

Seqens was founded in 2010 🔒.

What sector and industry vertical is Seqens in?

Seqens is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Seqens

Who are the top strategic acquirers in Seqens's sector and industry

Top strategic M&A buyers and acquirers in Seqens's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Seqens?

Top strategic M&A buyers groups and sectors for Seqens include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Seqens's sector and industry vertical

Which are the top PE firms investing in Seqens's sector and industry vertical?

Top PE firms investing in Seqens's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Seqens's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Seqens's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Seqens's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Seqens include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Seqens's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Seqens?

The key public trading comparables and valuation benchmarks for Seqens include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Seqens for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Seqens with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Seqens's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Seqens with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Seqens's' sector and industry vertical?

Access recent funding rounds and capital raises in Seqens's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Seqens